340 related articles for article (PubMed ID: 9514130)
1. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
[TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes.
Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
Am J Perinatol; 1998 Aug; 15(8):479-86. PubMed ID: 9788646
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis in viable mid-trimester pregnancies of normal, intrauterine growth retardation, chromosomal anomalies and hydrops fetalis and their eventual obstetric outcome.
Koh SC; Anandakumar C; Biswas A
J Perinat Med; 1999; 27(6):458-64. PubMed ID: 10732304
[TBL] [Abstract][Full Text] [Related]
4. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
5. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
[TBL] [Abstract][Full Text] [Related]
7. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
[TBL] [Abstract][Full Text] [Related]
8. Uteroplacental hemostasis in intrauterine fetal growth retardation.
Sheppard BL; Bonnar J
Semin Thromb Hemost; 1999; 25(5):443-6. PubMed ID: 10625199
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation.
Grancha S; Estellés A; Gilabert J; Chirivella M; España F; Aznar J
Thromb Haemost; 1996 Nov; 76(5):761-7. PubMed ID: 8950787
[TBL] [Abstract][Full Text] [Related]
10. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
11. [Blood coagulation and fibrinolytic studies in patients with toxemia of pregnancy].
Okamiya H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1557-64. PubMed ID: 2273312
[TBL] [Abstract][Full Text] [Related]
12. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
13. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy.
Ballegeer V; Mombaerts P; Declerck PJ; Spitz B; Van Assche FA; Collen D
Thromb Haemost; 1987 Dec; 58(4):1030-2. PubMed ID: 3445223
[TBL] [Abstract][Full Text] [Related]
15. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
[TBL] [Abstract][Full Text] [Related]
16. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
17. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
18. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
19. Platelet hemostatic capacity (PHC) and fibrinolytic inhibitors during pregnancy.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):449-51. PubMed ID: 9834012
[TBL] [Abstract][Full Text] [Related]
20. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation.
Schjetlein R; Haugen G; Wisløff F
Acta Obstet Gynecol Scand; 1997 Jul; 76(6):541-6. PubMed ID: 9246959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
